Zavaglia, C., Okolicsanyi, S., Cesarini, L., Mazzarelli, C., Pontecorvi, V., Ciaccio, A., et al. (2017). Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?. JOURNAL OF HEPATOLOGY, 66(1), 236-237 [10.1016/j.jhep.2016.08.016].

Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

OKOLICSANYI, STEFANO
Secondo
;
CIACCIO, ANTONIO;STRAZZABOSCO, MARIO
Penultimo
;
2017

Lettera in rivista
Hepatology, hepatocellular carcinoma, tumor recurrence
English
1-gen-2017
2017
66
1
236
237
reserved
Zavaglia, C., Okolicsanyi, S., Cesarini, L., Mazzarelli, C., Pontecorvi, V., Ciaccio, A., et al. (2017). Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?. JOURNAL OF HEPATOLOGY, 66(1), 236-237 [10.1016/j.jhep.2016.08.016].
File in questo prodotto:
File Dimensione Formato  
Zavaglia-2017-J Hepatology-VoR.pdf

Solo gestori archivio

Descrizione: Letter to the Editor
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 345.61 kB
Formato Adobe PDF
345.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/151692
Citazioni
  • Scopus 73
  • ???jsp.display-item.citation.isi??? 73
Social impact